These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18336089)

  • 1. An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion.
    McNaney CA; Drexler DM; Hnatyshyn SY; Zvyaga TA; Knipe JO; Belcastro JV; Sanders M
    Assay Drug Dev Technol; 2008 Feb; 6(1):121-9. PubMed ID: 18336089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates.
    Drexler DM; Belcastro JV; Dickinson KE; Edinger KJ; Hnatyshyn SY; Josephs JL; Langish RA; McNaney CA; Santone KS; Shipkova PA; Tymiak AA; Zvyaga TA; Sanders M
    Assay Drug Dev Technol; 2007 Apr; 5(2):247-64. PubMed ID: 17477833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates.
    Di L; Kerns EH; Hong Y; Kleintop TA; McConnell OJ; Huryn DM
    J Biomol Screen; 2003 Aug; 8(4):453-62. PubMed ID: 14567798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds.
    Grubb MF; Humphreys WG; Josephs JL
    Bioanalysis; 2012 Jul; 4(14):1747-61. PubMed ID: 22877221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
    Xu R; Manuel M; Cramlett J; Kassel DB
    J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis.
    Mortishire-Smith RJ; O'Connor D; Castro-Perez JM; Kirby J
    Rapid Commun Mass Spectrom; 2005; 19(18):2659-70. PubMed ID: 16124034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
    Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
    Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis Software.
    Shah P; Kerns E; Nguyen DT; Obach RS; Wang AQ; Zakharov A; McKew J; Simeonov A; Hop CE; Xu X
    Drug Metab Dispos; 2016 Oct; 44(10):1653-61. PubMed ID: 27417180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supercritical fluid chromatography/tandem mass spectrometric method for analysis of pharmaceutical compounds in metabolic stability samples.
    Hsieh Y; Favreau L; Schwerdt J; Cheng KC
    J Pharm Biomed Anal; 2006 Feb; 40(3):799-804. PubMed ID: 16095863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen.
    Kieltyka K; Zhang J; Li S; Vath M; Baglieri C; Ferraro C; Zvyaga TA; Drexler DM; Weller HN; Shou WZ
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1579-91. PubMed ID: 19399765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.
    Wong H; Grossman SJ; Bai SA; Diamond S; Wright MR; Grace JE; Qian M; He K; Yeleswaram K; Christ DD
    Drug Metab Dispos; 2004 Dec; 32(12):1359-69. PubMed ID: 15333515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries.
    Xu R; Nemes C; Jenkins KM; Rourick RA; Kassel DB; Liu CZ
    J Am Soc Mass Spectrom; 2002 Feb; 13(2):155-65. PubMed ID: 11841071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro ADME profiling using high-throughput rapidfire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays.
    Wu X; Wang J; Tan L; Bui J; Gjerstad E; McMillan K; Zhang W
    J Biomol Screen; 2012 Jul; 17(6):761-72. PubMed ID: 22460176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapid pharmacokinetics screening of drug candidates in vitro and in vivo].
    Dong XN; Zhu XX; Meng ZY; Liu JL; Cao YL; Dou GF
    Yao Xue Xue Bao; 2009 Nov; 44(11):1309-12. PubMed ID: 21355332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple strategies for reducing sample loads in in vitro metabolic stability high-throughput screening experiments: a comparison between traditional, two-time-point and pooled sample analyses.
    Zhao SX; Forman D; Wallace N; Smith BJ; Meyer D; Kazolias D; Gao F; Soglia J; Cole M; Nettleton D
    J Pharm Sci; 2005 Jan; 94(1):38-45. PubMed ID: 15761928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel supercritical fluid chromatography/mass spectrometry system for high-throughput enantioselective optimization and separation.
    Zeng L; Xu R; Laskar DB; Kassel DB
    J Chromatogr A; 2007 Oct; 1169(1-2):193-204. PubMed ID: 17900596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling.
    Wernevik J; Bergström F; Novén A; Hulthe J; Fredlund L; Addison D; Holmgren J; Strömstedt PE; Rehnström E; Lundböck T
    Assay Drug Dev Technol; 2020; 18(4):157-179. PubMed ID: 32407132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative metabolism and stability of andrographolide in liver microsomes from humans, dogs and rats using ultra-performance liquid chromatography coupled with triple-quadrupole and Fourier transform ion cyclotron resonance mass spectrometry.
    Zhao HY; Hu H; Wang YT
    Rapid Commun Mass Spectrom; 2013 Jun; 27(12):1385-92. PubMed ID: 23681817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstrain differences of in vitro metabolic stability and impact on early drug discovery.
    Richmond W; Wogan M; Isbell J; Gordon WP
    J Pharm Sci; 2010 Nov; 99(11):4463-8. PubMed ID: 20845445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.